Loading…
Colorectal Cancer Is a Paracrine Deficiency Syndrome Amenable to Oral Hormone Replacement Therapy
The most commonly lost gene products in colorectal carcinogenesis include the paracrine hormones guanylin and uroguanylin, the endogenous ligands for guanylyl cyclase C (GCC), the intestinal receptor for diarrheagenic bacterial enterotoxins. Recently, GCC‐cyclic guanosine monophosphate (GMP) signali...
Saved in:
Published in: | Clinical and translational science 2008-09, Vol.1 (2), p.163-167 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Request full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5690-2eb0e7773f8a3f028298a7a12f9712288ea206a8d0bf5a1c68b4242dcb67706a3 |
---|---|
cites | cdi_FETCH-LOGICAL-c5690-2eb0e7773f8a3f028298a7a12f9712288ea206a8d0bf5a1c68b4242dcb67706a3 |
container_end_page | 167 |
container_issue | 2 |
container_start_page | 163 |
container_title | Clinical and translational science |
container_volume | 1 |
creator | Li, Peng Lin, Jieru E. Snook, Adam E. Gibbons, Ahmara V. Zuzga, David S. Schulz, Stephanie Pitari, Giovanni M. Waldman, Scott A. |
description | The most commonly lost gene products in colorectal carcinogenesis include the paracrine hormones guanylin and uroguanylin, the endogenous ligands for guanylyl cyclase C (GCC), the intestinal receptor for diarrheagenic bacterial enterotoxins. Recently, GCC‐cyclic guanosine monophosphate (GMP) signaling has emerged as a principal regulator of proliferation, genetic integrity, and metabolic programming in normal human enterocytes and colon cancer cells. Elimination of GCC in mice produced hyperplasia of the proliferating compartment associated with increases in the rapidly cycling progenitor cells and reprogrammed enterocyte metabolism, with a shift from oxidative phosphorylation to glycolysis. In addition, in the colons of mice carrying mutations in adenomatous polyposis coli gene Apc (ApcMin/+) or exposed to the carcinogen azoxymethane, elimination of GCC increased tumor initiation and promotion by disrupting genomic integrity and releasing cell cycle restriction. These previously unrecognized roles for GCC as a fundamental regulator of intestinal homeostasis and as an intestinal tumor suppressor suggest that receptor dysregulation reflecting paracrine hormone insuffciency is a key event during the initial stages of colorectal tumorigenesis. Together with the uniform overexpression of GCC in human tumors, these novel roles for GCC underscore the potential of oral replacement with GCC ligands for a targeted prevention and therapy of colorectal cancer. |
doi_str_mv | 10.1111/j.1752-8062.2008.00040.x |
format | article |
fullrecord | <record><control><sourceid>proquest_24P</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2707021</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20745196</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5690-2eb0e7773f8a3f028298a7a12f9712288ea206a8d0bf5a1c68b4242dcb67706a3</originalsourceid><addsrcrecordid>eNqNkV9v0zAUxSMEYmPwFZAlJN5Srp04diSENAVYJw2GtgKP1o17w1KSuNgpNN8el1blzxN-8ZXO7xzdq5MkjMOMx_diNeNKilRDIWYCQM8AIIfZ9l5yehTuH2eZnySPQlgBFFmh5cPkhJdKqDyTpwlWrnOe7Igdq3Cw5NllYMg-oEfr24HYa2pa29JgJ3Y7DUvvemLnPQ1Yd8RGx659tM6d712Eb2jdoaUoj2xxRx7X0-PkQYNdoCeH_yz5-PbNopqnV9cXl9X5VWplUUIqqAZSSmWNxqwBoUWpUSEXTam4EFoTCihQL6FuJHJb6DoXuVjaulAqCtlZ8mqfu97UPS1tXCFuZta-7dFPxmFr_laG9s58cd-NUKBA8Bjw_BDg3bcNhdH0bbDUdTiQ2wQjQOWSl0UEn_0DrtzGD_E4I7KylDITXEZK7ynrXQiemuMqHMyuRbMyu4LMriyza9H8atFso_Xpn6f8Nh5qi8DLPfCj7Wj672BTLW7jEO3p3t6GkbZHO_qvplCZkubz-wvzCd6Jm3kB8aafI8i57Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2399553215</pqid></control><display><type>article</type><title>Colorectal Cancer Is a Paracrine Deficiency Syndrome Amenable to Oral Hormone Replacement Therapy</title><source>Wiley Online Library Open Access</source><creator>Li, Peng ; Lin, Jieru E. ; Snook, Adam E. ; Gibbons, Ahmara V. ; Zuzga, David S. ; Schulz, Stephanie ; Pitari, Giovanni M. ; Waldman, Scott A.</creator><creatorcontrib>Li, Peng ; Lin, Jieru E. ; Snook, Adam E. ; Gibbons, Ahmara V. ; Zuzga, David S. ; Schulz, Stephanie ; Pitari, Giovanni M. ; Waldman, Scott A.</creatorcontrib><description>The most commonly lost gene products in colorectal carcinogenesis include the paracrine hormones guanylin and uroguanylin, the endogenous ligands for guanylyl cyclase C (GCC), the intestinal receptor for diarrheagenic bacterial enterotoxins. Recently, GCC‐cyclic guanosine monophosphate (GMP) signaling has emerged as a principal regulator of proliferation, genetic integrity, and metabolic programming in normal human enterocytes and colon cancer cells. Elimination of GCC in mice produced hyperplasia of the proliferating compartment associated with increases in the rapidly cycling progenitor cells and reprogrammed enterocyte metabolism, with a shift from oxidative phosphorylation to glycolysis. In addition, in the colons of mice carrying mutations in adenomatous polyposis coli gene Apc (ApcMin/+) or exposed to the carcinogen azoxymethane, elimination of GCC increased tumor initiation and promotion by disrupting genomic integrity and releasing cell cycle restriction. These previously unrecognized roles for GCC as a fundamental regulator of intestinal homeostasis and as an intestinal tumor suppressor suggest that receptor dysregulation reflecting paracrine hormone insuffciency is a key event during the initial stages of colorectal tumorigenesis. Together with the uniform overexpression of GCC in human tumors, these novel roles for GCC underscore the potential of oral replacement with GCC ligands for a targeted prevention and therapy of colorectal cancer.</description><identifier>ISSN: 1752-8054</identifier><identifier>EISSN: 1752-8062</identifier><identifier>DOI: 10.1111/j.1752-8062.2008.00040.x</identifier><identifier>PMID: 19727435</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>Adenomatous polyposis coli ; Adenomatous polyposis coli protein ; Administration, Oral ; Animals ; Apoptosis ; Azoxymethane ; Biosynthesis ; Carcinogenesis ; Cell cycle ; Colon cancer ; Colorectal cancer ; Colorectal carcinoma ; Colorectal Neoplasms - enzymology ; Colorectal Neoplasms - pathology ; Colorectal Neoplasms - prevention & control ; Colorectal Neoplasms - therapy ; Cyclic GMP ; Dehydrogenases ; Electrolytes ; Enterocytes ; Enterotoxins ; Glycolysis ; Guanosine ; Guanylate cyclase ; Guanylate Cyclase - antagonists & inhibitors ; Homeostasis ; Hormone Replacement Therapy ; Humans ; Hyperplasia ; Intestine ; Kinases ; Ligands ; Metabolism ; Mice ; Mitochondrial DNA ; Oxidative phosphorylation ; Paracrine Communication ; paracrine deficiency syndrome ; Paracrine signalling ; Peptides ; Phosphorylation ; Physiology ; Polyposis coli ; Precancerous Conditions - enzymology ; Precancerous Conditions - pathology ; Proteins ; Receptors, Enterotoxin ; Receptors, Guanylate Cyclase-Coupled ; Receptors, Peptide - antagonists & inhibitors ; Signal Transduction ; Small intestine ; Stem cells ; Syndrome ; Tumor suppressor genes ; Tumor Suppressor Proteins - metabolism ; Tumorigenesis</subject><ispartof>Clinical and translational science, 2008-09, Vol.1 (2), p.163-167</ispartof><rights>2008 Wiley Periodicals, Inc.</rights><rights>Copyright John Wiley & Sons, Inc. Sep 2008</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5690-2eb0e7773f8a3f028298a7a12f9712288ea206a8d0bf5a1c68b4242dcb67706a3</citedby><cites>FETCH-LOGICAL-c5690-2eb0e7773f8a3f028298a7a12f9712288ea206a8d0bf5a1c68b4242dcb67706a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707021/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707021/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,27924,27925,46052,46476,53791,53793</link.rule.ids><linktorsrc>$$Uhttps://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1752-8062.2008.00040.x$$EView_record_in_Wiley-Blackwell$$FView_record_in_$$GWiley-Blackwell</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19727435$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Peng</creatorcontrib><creatorcontrib>Lin, Jieru E.</creatorcontrib><creatorcontrib>Snook, Adam E.</creatorcontrib><creatorcontrib>Gibbons, Ahmara V.</creatorcontrib><creatorcontrib>Zuzga, David S.</creatorcontrib><creatorcontrib>Schulz, Stephanie</creatorcontrib><creatorcontrib>Pitari, Giovanni M.</creatorcontrib><creatorcontrib>Waldman, Scott A.</creatorcontrib><title>Colorectal Cancer Is a Paracrine Deficiency Syndrome Amenable to Oral Hormone Replacement Therapy</title><title>Clinical and translational science</title><addtitle>Clin Transl Sci</addtitle><description>The most commonly lost gene products in colorectal carcinogenesis include the paracrine hormones guanylin and uroguanylin, the endogenous ligands for guanylyl cyclase C (GCC), the intestinal receptor for diarrheagenic bacterial enterotoxins. Recently, GCC‐cyclic guanosine monophosphate (GMP) signaling has emerged as a principal regulator of proliferation, genetic integrity, and metabolic programming in normal human enterocytes and colon cancer cells. Elimination of GCC in mice produced hyperplasia of the proliferating compartment associated with increases in the rapidly cycling progenitor cells and reprogrammed enterocyte metabolism, with a shift from oxidative phosphorylation to glycolysis. In addition, in the colons of mice carrying mutations in adenomatous polyposis coli gene Apc (ApcMin/+) or exposed to the carcinogen azoxymethane, elimination of GCC increased tumor initiation and promotion by disrupting genomic integrity and releasing cell cycle restriction. These previously unrecognized roles for GCC as a fundamental regulator of intestinal homeostasis and as an intestinal tumor suppressor suggest that receptor dysregulation reflecting paracrine hormone insuffciency is a key event during the initial stages of colorectal tumorigenesis. Together with the uniform overexpression of GCC in human tumors, these novel roles for GCC underscore the potential of oral replacement with GCC ligands for a targeted prevention and therapy of colorectal cancer.</description><subject>Adenomatous polyposis coli</subject><subject>Adenomatous polyposis coli protein</subject><subject>Administration, Oral</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Azoxymethane</subject><subject>Biosynthesis</subject><subject>Carcinogenesis</subject><subject>Cell cycle</subject><subject>Colon cancer</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Colorectal Neoplasms - enzymology</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Colorectal Neoplasms - prevention & control</subject><subject>Colorectal Neoplasms - therapy</subject><subject>Cyclic GMP</subject><subject>Dehydrogenases</subject><subject>Electrolytes</subject><subject>Enterocytes</subject><subject>Enterotoxins</subject><subject>Glycolysis</subject><subject>Guanosine</subject><subject>Guanylate cyclase</subject><subject>Guanylate Cyclase - antagonists & inhibitors</subject><subject>Homeostasis</subject><subject>Hormone Replacement Therapy</subject><subject>Humans</subject><subject>Hyperplasia</subject><subject>Intestine</subject><subject>Kinases</subject><subject>Ligands</subject><subject>Metabolism</subject><subject>Mice</subject><subject>Mitochondrial DNA</subject><subject>Oxidative phosphorylation</subject><subject>Paracrine Communication</subject><subject>paracrine deficiency syndrome</subject><subject>Paracrine signalling</subject><subject>Peptides</subject><subject>Phosphorylation</subject><subject>Physiology</subject><subject>Polyposis coli</subject><subject>Precancerous Conditions - enzymology</subject><subject>Precancerous Conditions - pathology</subject><subject>Proteins</subject><subject>Receptors, Enterotoxin</subject><subject>Receptors, Guanylate Cyclase-Coupled</subject><subject>Receptors, Peptide - antagonists & inhibitors</subject><subject>Signal Transduction</subject><subject>Small intestine</subject><subject>Stem cells</subject><subject>Syndrome</subject><subject>Tumor suppressor genes</subject><subject>Tumor Suppressor Proteins - metabolism</subject><subject>Tumorigenesis</subject><issn>1752-8054</issn><issn>1752-8062</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqNkV9v0zAUxSMEYmPwFZAlJN5Srp04diSENAVYJw2GtgKP1o17w1KSuNgpNN8el1blzxN-8ZXO7xzdq5MkjMOMx_diNeNKilRDIWYCQM8AIIfZ9l5yehTuH2eZnySPQlgBFFmh5cPkhJdKqDyTpwlWrnOe7Igdq3Cw5NllYMg-oEfr24HYa2pa29JgJ3Y7DUvvemLnPQ1Yd8RGx659tM6d712Eb2jdoaUoj2xxRx7X0-PkQYNdoCeH_yz5-PbNopqnV9cXl9X5VWplUUIqqAZSSmWNxqwBoUWpUSEXTam4EFoTCihQL6FuJHJb6DoXuVjaulAqCtlZ8mqfu97UPS1tXCFuZta-7dFPxmFr_laG9s58cd-NUKBA8Bjw_BDg3bcNhdH0bbDUdTiQ2wQjQOWSl0UEn_0DrtzGD_E4I7KylDITXEZK7ynrXQiemuMqHMyuRbMyu4LMriyza9H8atFso_Xpn6f8Nh5qi8DLPfCj7Wj672BTLW7jEO3p3t6GkbZHO_qvplCZkubz-wvzCd6Jm3kB8aafI8i57Q</recordid><startdate>200809</startdate><enddate>200809</enddate><creator>Li, Peng</creator><creator>Lin, Jieru E.</creator><creator>Snook, Adam E.</creator><creator>Gibbons, Ahmara V.</creator><creator>Zuzga, David S.</creator><creator>Schulz, Stephanie</creator><creator>Pitari, Giovanni M.</creator><creator>Waldman, Scott A.</creator><general>Blackwell Publishing Inc</general><general>John Wiley & Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7QL</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>200809</creationdate><title>Colorectal Cancer Is a Paracrine Deficiency Syndrome Amenable to Oral Hormone Replacement Therapy</title><author>Li, Peng ; Lin, Jieru E. ; Snook, Adam E. ; Gibbons, Ahmara V. ; Zuzga, David S. ; Schulz, Stephanie ; Pitari, Giovanni M. ; Waldman, Scott A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5690-2eb0e7773f8a3f028298a7a12f9712288ea206a8d0bf5a1c68b4242dcb67706a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adenomatous polyposis coli</topic><topic>Adenomatous polyposis coli protein</topic><topic>Administration, Oral</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Azoxymethane</topic><topic>Biosynthesis</topic><topic>Carcinogenesis</topic><topic>Cell cycle</topic><topic>Colon cancer</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Colorectal Neoplasms - enzymology</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Colorectal Neoplasms - prevention & control</topic><topic>Colorectal Neoplasms - therapy</topic><topic>Cyclic GMP</topic><topic>Dehydrogenases</topic><topic>Electrolytes</topic><topic>Enterocytes</topic><topic>Enterotoxins</topic><topic>Glycolysis</topic><topic>Guanosine</topic><topic>Guanylate cyclase</topic><topic>Guanylate Cyclase - antagonists & inhibitors</topic><topic>Homeostasis</topic><topic>Hormone Replacement Therapy</topic><topic>Humans</topic><topic>Hyperplasia</topic><topic>Intestine</topic><topic>Kinases</topic><topic>Ligands</topic><topic>Metabolism</topic><topic>Mice</topic><topic>Mitochondrial DNA</topic><topic>Oxidative phosphorylation</topic><topic>Paracrine Communication</topic><topic>paracrine deficiency syndrome</topic><topic>Paracrine signalling</topic><topic>Peptides</topic><topic>Phosphorylation</topic><topic>Physiology</topic><topic>Polyposis coli</topic><topic>Precancerous Conditions - enzymology</topic><topic>Precancerous Conditions - pathology</topic><topic>Proteins</topic><topic>Receptors, Enterotoxin</topic><topic>Receptors, Guanylate Cyclase-Coupled</topic><topic>Receptors, Peptide - antagonists & inhibitors</topic><topic>Signal Transduction</topic><topic>Small intestine</topic><topic>Stem cells</topic><topic>Syndrome</topic><topic>Tumor suppressor genes</topic><topic>Tumor Suppressor Proteins - metabolism</topic><topic>Tumorigenesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Peng</creatorcontrib><creatorcontrib>Lin, Jieru E.</creatorcontrib><creatorcontrib>Snook, Adam E.</creatorcontrib><creatorcontrib>Gibbons, Ahmara V.</creatorcontrib><creatorcontrib>Zuzga, David S.</creatorcontrib><creatorcontrib>Schulz, Stephanie</creatorcontrib><creatorcontrib>Pitari, Giovanni M.</creatorcontrib><creatorcontrib>Waldman, Scott A.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical and translational science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Li, Peng</au><au>Lin, Jieru E.</au><au>Snook, Adam E.</au><au>Gibbons, Ahmara V.</au><au>Zuzga, David S.</au><au>Schulz, Stephanie</au><au>Pitari, Giovanni M.</au><au>Waldman, Scott A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Colorectal Cancer Is a Paracrine Deficiency Syndrome Amenable to Oral Hormone Replacement Therapy</atitle><jtitle>Clinical and translational science</jtitle><addtitle>Clin Transl Sci</addtitle><date>2008-09</date><risdate>2008</risdate><volume>1</volume><issue>2</issue><spage>163</spage><epage>167</epage><pages>163-167</pages><issn>1752-8054</issn><eissn>1752-8062</eissn><abstract>The most commonly lost gene products in colorectal carcinogenesis include the paracrine hormones guanylin and uroguanylin, the endogenous ligands for guanylyl cyclase C (GCC), the intestinal receptor for diarrheagenic bacterial enterotoxins. Recently, GCC‐cyclic guanosine monophosphate (GMP) signaling has emerged as a principal regulator of proliferation, genetic integrity, and metabolic programming in normal human enterocytes and colon cancer cells. Elimination of GCC in mice produced hyperplasia of the proliferating compartment associated with increases in the rapidly cycling progenitor cells and reprogrammed enterocyte metabolism, with a shift from oxidative phosphorylation to glycolysis. In addition, in the colons of mice carrying mutations in adenomatous polyposis coli gene Apc (ApcMin/+) or exposed to the carcinogen azoxymethane, elimination of GCC increased tumor initiation and promotion by disrupting genomic integrity and releasing cell cycle restriction. These previously unrecognized roles for GCC as a fundamental regulator of intestinal homeostasis and as an intestinal tumor suppressor suggest that receptor dysregulation reflecting paracrine hormone insuffciency is a key event during the initial stages of colorectal tumorigenesis. Together with the uniform overexpression of GCC in human tumors, these novel roles for GCC underscore the potential of oral replacement with GCC ligands for a targeted prevention and therapy of colorectal cancer.</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>19727435</pmid><doi>10.1111/j.1752-8062.2008.00040.x</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | ISSN: 1752-8054 |
ispartof | Clinical and translational science, 2008-09, Vol.1 (2), p.163-167 |
issn | 1752-8054 1752-8062 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2707021 |
source | Wiley Online Library Open Access |
subjects | Adenomatous polyposis coli Adenomatous polyposis coli protein Administration, Oral Animals Apoptosis Azoxymethane Biosynthesis Carcinogenesis Cell cycle Colon cancer Colorectal cancer Colorectal carcinoma Colorectal Neoplasms - enzymology Colorectal Neoplasms - pathology Colorectal Neoplasms - prevention & control Colorectal Neoplasms - therapy Cyclic GMP Dehydrogenases Electrolytes Enterocytes Enterotoxins Glycolysis Guanosine Guanylate cyclase Guanylate Cyclase - antagonists & inhibitors Homeostasis Hormone Replacement Therapy Humans Hyperplasia Intestine Kinases Ligands Metabolism Mice Mitochondrial DNA Oxidative phosphorylation Paracrine Communication paracrine deficiency syndrome Paracrine signalling Peptides Phosphorylation Physiology Polyposis coli Precancerous Conditions - enzymology Precancerous Conditions - pathology Proteins Receptors, Enterotoxin Receptors, Guanylate Cyclase-Coupled Receptors, Peptide - antagonists & inhibitors Signal Transduction Small intestine Stem cells Syndrome Tumor suppressor genes Tumor Suppressor Proteins - metabolism Tumorigenesis |
title | Colorectal Cancer Is a Paracrine Deficiency Syndrome Amenable to Oral Hormone Replacement Therapy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T22%3A48%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_24P&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Colorectal%20Cancer%20Is%20a%20Paracrine%20Deficiency%20Syndrome%20Amenable%20to%20Oral%20Hormone%20Replacement%20Therapy&rft.jtitle=Clinical%20and%20translational%20science&rft.au=Li,%20Peng&rft.date=2008-09&rft.volume=1&rft.issue=2&rft.spage=163&rft.epage=167&rft.pages=163-167&rft.issn=1752-8054&rft.eissn=1752-8062&rft_id=info:doi/10.1111/j.1752-8062.2008.00040.x&rft_dat=%3Cproquest_24P%3E20745196%3C/proquest_24P%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5690-2eb0e7773f8a3f028298a7a12f9712288ea206a8d0bf5a1c68b4242dcb67706a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2399553215&rft_id=info:pmid/19727435&rfr_iscdi=true |